Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

CRMP

CRMP

Unknown Manufacturer

Generate AI report

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

Method for identifying CRMP modulators
Applicant: SANOL ARZNEI SCHWARZ GMBHPriority: 2006
EP
METHOD FOR IDENTIFYING CRMP MODULATORS
Applicant: BEYREUTHER BETTINAPriority: 2006
US
Chlamydia 60 Kda CRMP antigens and vaccine uses
Applicant: SANOFI PASTEUR LTDPriority: 2007
US
2 publications
Collapsin response mediator protein-1 (CRMP-1) transcriptional regulatory nucleic acid sequences
Applicant: YANG PAN-CHYRPriority: 2005
US
4 publications
Compositions and methods of using CRMP-1 and its fragments for treating cancer
Applicant: ADVPHARMA INCPriority: 2008
US
3 publications
Use of a novel human ULIP6/CRMP protein in diagnosis of paraneoplastic neurological syndromes
Applicant: INST NAT SANTE RECH MEDPriority: 2000
US
6 publications
Use of a protein of the crmp family for treating diseases related to the immune system
Applicant: GIRAUDON PASCALEPriority: 2001
US
2 publications
Use of Ulip-and/or Ulip2 in the treatment of myelin disorders
Applicant: AGUERA MICHELLEPriority: 2001
US